Rubius Therapeutics, Inc. (RUBY)

OTCMKTS: RUBY · Delayed Price · USD
-0.0001 (-0.50%)
Mar 17, 2023, 12:00 AM EDT - Market open

Total Valuation

RUBY has a market cap or net worth of $1.80 million. The enterprise value is -$11.86 million.

Market Cap 1.80M
Enterprise Value -11.86M

Important Dates

The last earnings date was Friday, March 10, 2023, before market open.

Last Earnings Date Mar 10, 2023
Ex-Dividend Date n/a

Share Statistics

RUBY has 90.48 million shares outstanding. The number of shares has increased by 0.43% in one year.

Shares Outstanding 90.48M
Shares Change (YoY) +0.43%
Shares Change (QoQ) -0.07%
Owned by Insiders (%) 5.50%
Owned by Institutions (%) 67.16%
Float 46.91M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.13
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.07.

Current Ratio 2.54
Quick Ratio n/a
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -133.10%.

Return on Equity (ROE) -133.10%
Return on Assets (ROA) -87.30%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$19.96M
Employee Count 9
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.65% in the last 52 weeks. The beta is 2.51, so RUBY's price volatility has been higher than the market average.

Beta (1Y) 2.51
52-Week Price Change -99.65%
50-Day Moving Average 0.18
200-Day Moving Average 0.47
Average Volume (30 Days) 4,535,714

Short Selling Information

The latest short interest is 1.53 million, so 1.69% of the outstanding shares have been sold short.

Short Interest 1.53M
Short Previous Month 1.87M
Short % of Shares Out 1.69%
Short % of Float 3.26%
Short Ratio (days to cover) 0.49

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -178.45M
Pretax Income -179.67M
Net Income -179.67M
EBITDA -169.85M
EBIT -175.80M
Earnings Per Share (EPS) -$1.99
Full Income Statement

Balance Sheet

The company has $14.87 million in cash and $1.10 million in debt, giving a net cash position of $13.77 million or $0.15 per share.

Cash & Cash Equivalents 14.87M
Total Debt 1.10M
Net Cash 13.77M
Net Cash Per Share $0.15
Equity / Book Value 15.13M
Book Value Per Share 0.17
Working Capital 12.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$150.14 million and capital expenditures -$5.30 million, giving a free cash flow of -$155.45 million.

Operating Cash Flow -150.14M
Capital Expenditures -5.30M
Free Cash Flow -155.45M
FCF Per Share -$1.72
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RUBY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -9,455.39%
FCF Yield -8,180.75%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -0.43%
Shareholder Yield -0.43%
Dividend Details

Analyst Forecast

The average price target for RUBY is $1.02, which is 5,025.63% higher than the current price. The consensus rating is "Sell".

Price Target $1.02
Price Target Difference 5,025.63%
Analyst Consensus Sell
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a